cilostamide has been researched along with sildenafil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbosa, J; Barrish, JC; Brown, B; Dodd, JH; Donaldson, K; Guo, J; Huynh, T; Kiener, PA; Leftheris, K; Pitts, WJ; Poss, MA; Roberge, JY; Starling, GC; Vaccaro, W; Watson, A | 1 |
Hughes, RA; Manallack, DT; Thompson, PE | 1 |
Chen, G; Ke, H; Kunz, S; Martinelli, S; Robinson, H; Seebeck, T; Wan, Y; Wang, H | 1 |
1 review(s) available for cilostamide and sildenafil
Article | Year |
---|---|
The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP; Cyclic GMP; Drug Design; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Quantitative Structure-Activity Relationship; Xanthines | 2005 |
2 other study(ies) available for cilostamide and sildenafil
Article | Year |
---|---|
Identification of purine inhibitors of phosphodiesterase 7 (PDE7).
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Binding Sites; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 7; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Ligands; Purines; Structure-Activity Relationship; T-Lymphocytes | 2004 |
Biological and structural characterization of Trypanosoma cruzi phosphodiesterase C and Implications for design of parasite selective inhibitors.
Topics: Amino Acid Sequence; Bridged Bicyclo Compounds, Heterocyclic; Catalytic Domain; Conserved Sequence; Crystallography, X-Ray; Drug Design; Kinetics; Molecular Sequence Data; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Binding; Protein Structure, Secondary; Protozoan Proteins; Recombinant Proteins; Saccharomyces cerevisiae; Sulfonamides; Surface Properties; Trypanosoma cruzi | 2012 |